# RIBAVIRIN
> **ANDA207366** · Abbreviated New Drug Application (Generic) · Sponsor: NAVINTA LLC · Approved 2016-10-06
## Drug
- **FDA Application Number:** ANDA207366
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIBAVIRIN
- **Generic name:** RIBAVIRIN
- **Active ingredients:** RIBAVIRIN
- **Dosage form:** FOR SOLUTION
- **Route:** INHALATION
- **Marketing status:** Discontinued
- **Sponsor:** NAVINTA LLC
- **Manufacturer:** Navinta LLC
- **First approval:** 2016-10-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207366)
---
*MORVS · CC0 1.0*